Securities Fraud Investigation Into aTyr Pharma Inc. (ATYR) Announced - Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Business Wire 15-Oct-2025 6:40 PM

The Law Offices of Frank R. Cruz announces an investigation of aTyr Pharma Inc. ("aTyr" or the "Company") (NASDAQ: ATYR) on behalf of investors concerning the Company's possible violations of federal securities laws.

IF YOU ARE AN INVESTOR WHO LOST MONEY ON ATYR PHARMA INC. (ATYR), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.

What Is The Investigation About?

On September 15, 2025, aTyr announced that the Phase 3 study of its intravenous Efzofitimod pulmonary sarcoidosis treatment, EFZO-FIT, did not meet its primary endpoint in change from baseline in mean daily OSC dose at week 48.

On this news, aTyr's stock price fell $5.01, or 83.2%, to close at $1.02 per share on September 15, 2025, thereby injuring investors.

Contact Us To Participate or Learn More:

If you purchased aTyr securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:

The Law Offices of Frank R. Cruz, 2121 Avenue of the Stars, Suite 800, Century City, California 90067 Call us at: 310-914-5007 Email us at: info@frankcruzlaw.com Visit our website at: www.frankcruzlaw.com. Follow us for updates on Twitter at twitter.com/FRC_LAW.

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251015099848/en/

Contact Us: The Law Offices of Frank R. Cruz, Los Angeles Frank R. Cruz 310-914-5007 fcruz@frankcruzlaw.com www.frankcruzlaw.com